Form 4: Equillium Inc. Principal Accounting Officer Acquires Stock Options

Equillium Inc.'s Principal Accounting Officer, Tom Penny, was granted 125,000 stock options on January 2, 2025.

Summary

• Tom Penny, the Principal Accounting Officer of Equillium Inc., was granted 125,000 employee stock options on January 2, 2025.
• The options have an exercise price of $0.77 per share.
• The options vest over a period of four years, with 25% vesting on the first anniversary of the vesting commencement date and the remaining 75% vesting in 36 equal monthly installments thereafter.
• The options expire on January 1, 2035.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of executive compensation, which is generally viewed positively as it aligns management's interests with shareholders. There are no negative implications.

Positives

• The granting of stock options to a key officer aligns their interests with the company's long-term success.
• The vesting schedule encourages long-term commitment from the officer.

Industry Context

Stock option grants are a common form of compensation for executives in publicly traded companies, aligning their interests with shareholders and incentivizing long-term performance.

Comparison to Industry Standards

• Stock option grants are a standard practice for executive compensation across the biotechnology industry.
• The vesting schedule of 25% after one year and the remainder over three years is a typical vesting structure for stock options.

Stakeholder Impact

• The stock option grant may have a minor positive impact on shareholder sentiment as it aligns management's interests with the company's long-term success.

Key Dates

Keywords

stock options, insider trading, equity compensation, vesting, Equillium Inc., Tom Penny